Member Info for Dazpink

BearedDragon, why worrying news, it is a completely different market. It happened to PureTech Health US: PureTech Health, a clinical-stage biotherapeutics company declined an approach from Nordic Capital last week.

WG are an established market leading global company in engineering/Infrastructure build

The owners of British Gas and Johnson Matthey have teamed up with JCB scion Jo Bamford to launch a £6.5 billion project to dramatically increase Britain's hydrogen production.

Engineering giant Arup, cement-maker Heidelberg, the building materials company Tarmac and the pipeline business National Gas, are also among a heavy coalition led by Bamford, which has submitted proposals to energy secretary Ed Miliband.

The consortium, Project HySpeed, wants to build one gigawatt of green hydrogen production capacity in the UK by 2030. They estimate that it would attract £6.5 billion of private investment and create 24,300 jobs, with at least half of them in this country.

The government's 2023 Hydrogen Production Delivery Roadmap is targeting ten gigawatts of low-carbon hydrogen production by 2030. To support this, ministers introduced “Hydrogen Allocation Rounds” that offer subsidies to hydrogen producers through a “contracts for difference” mechanism, which guarantees a minimum price to investors.

Ministers also asked for businesses to submit larger individual proposals, and Project Hyspeed is a response to this. Should it go ahead, it would be the largest hydrogen project in the country, and one of the largest in the world.

Hydrogen is one of the cleanest forms of energy. Burned with oxygen, the chemical reaction releases three times more energy than petrol with water the only byproduct.

Former prime minister Boris Johnson was a major advocate during his time in Downing Street, claiming the public could “cook your breakfast using hydrogen power before getting in your electric car” each morning.

Rachel Reeves, the chancellor has earmarked £2 billion for 11 new green hydrogen projects, from Devon to the Scottish Highlands.

Scepticism about hydrogen as an energy source abounds, however. Not only is it expensive to produce but critics claim it could be dangerous if used for home heating, an allegation that is hotly disputed by hydrogen advocates. They say that home boilers powered by natural gas are more dangerous because of the potential for carbon monoxide poisoning.

The group behind Project Hyspeed claims that building at scale is key to bringing the price down. Documents submitted to Miliband's team claim that Hypseed can deliver hydrogen at a strike price of £5.96/kg — far lower than the £9.50/kg strike price offered to those participating in the first Hydrogen Allocation Round.

Chris O'Shea, chief executive of British Gas owner Centrica, said: “There is no silver bullet to decarbonise the energy system. It will take every technology at our disposal. The scale and ambition of this project has the potential to dramatically lower costs, making hydrogen roll-out affordable for the government and the private sector alike.”

Article on the times today,

UK businesses plan £6.5bn project to raise hydrogen production.

The government's 2023 Hydrogen Production Delivery Roadmap is targeting ten gigawatts of low-carbon hydrogen production by 2030. To support this, ministers introduced “Hydrogen Allocation Rounds” that offer subsidies to hydrogen producers through a “contracts for difference” mechanism, which guarantees a minimum price to investors.

I would expect WG to be selected for some of the contracts based on experience and technical knowledge.

https://www.woodplc.com/solutions/key-markets/energy/hydrogen

Below is a list of fund holders and Institutional Investors that are invested in WG. I would have thought that all would have been busy last week and this weekend negotiating a good deal for them.

Top Institutional Holders

Holder

% of holding

Shares Held

Date Reported

Value (In 1,000s)

* Hargreaves Lansdown Asset Management Ltd. 9.22% 63,415,917 Mar 03, 2025 15,854

* Schroder Investment Management Limited 5.15% 35,379,116 Mar 26, 2025 8,845

* BlackRock, Inc. 5.09% 35,009,327 Apr 07, 2025 8,752

* The Vanguard Group, Inc. 4.93% 33,912,583 Mar 03, 2025 8,478

* Ninety One UK Limited 4.34% 29,807,918 Mar 03, 2025 7,452

* Marathon Asset Management Limited 4.06% 27,927,508 Mar 03, 2025 6,982

* FMR LLC 3.64% 24,993,576 Mar 14, 2025 6,248

* Fidelity International Ltd 3.64% 24,993,576 Mar 14, 2025 6,248

* HBOS Investment Fund Managers Limited 3.55% 24,432,390 Mar 03, 2025 6,108

* Goldman Sachs Group, Investment Banking and Securities Investments 3.35% 23,000,637 Mar 03, 2025 5,750

Top Mutual Fund Holders

Holder

% of holding

Shares Held

Date Reported

Value (In 1,000s)

* Fidelity Investment Funds - Special Situations Fund 3.40% 23,342,303 Aug 31, 2024 5,836

* Fidelity Puritan Trust - Fidelity Low-Priced Stock Fund 3.19% 21,964,519 Dec 31, 2024 5,491

* Border To Coast Authorised Contractual Scheme - Border To Coast Global * Equity Alpha Fund 2.12% 14,594,979 Sep 30, 2024 3,649

* Fidelity Investment Trust - Fidelity International Small Cap Fund 1.72% 11,829,800 Jan 31, 2025 2,957

* Schroder Unit Trusts Limited - Schroder Recovery Fund 1.58% 10,845,796 Jan 15, 2024 2,711

* Vanguard STAR Funds - Vanguard Total International Stock ETF 1.40% 9,655,246 Feb 28, 2025 2,414

* UK Growth Fund 1.35% 9,289,901 Dec 31, 2023 2,322

* Ninety One Funds Series i - UK Special Situations Fund 1.30% 8,934,680 Sep 30, 2024 2,234

* St James's Place UK Unit Trust 1.21% 8,325,652 Sep 30, 2024 2,081

* Schroder International Selection Fund SICAV - Global Energy 1.02% 7,036,445 Jun 30, 2024 1,759

Thanks jenashon, it great to all pull together and avoid the negative poor taste comments and focus on what is real. We all have invested x amount of pounds into this company and me personally don’t want anyone one of us to lose financially.

Hi MarkGo,

No problem, my point is to demonstrate that with or without Sidara, WG will benefit. The amount of projects that are coming in on the back of energy transition is mega. Sidara are heavily involved and will know that WG are gaining traction in this sector.

The White House in March 2025 announced that the UAE has committed to a $1.4 trillion investment framework in the US related to artificial intelligence infrastructure, semiconductors, energy and manufacturing.

At the bottom of the article

The announcement of the framework – which will be over a period of 10 years – followed a series of meetings between US and UAE officials, led by Sheikh Tahnoon bin Zayed, Deputy Ruler of Abu Dhabi and National Security Adviser, last month.

Sidara want WG as it is one of the world’s leading consulting and engineering companies operating across energy markets not a AIM small turnover company.

Deadline 17 April

Expect massive UAE investments in US, says American Energy Secretary

https://www.thenationalnews.com/business/energy/2025/04/10/energy-us-uae-ai/

Https://sidaracollaborative.com/projects/eet-hydrogen-plant

MarkGo, Sidara have some huge infrastructure projects both in the uk and globally. I live near the Humber and a project that Sidara are involved in is in progress. See below.

The "Sidara pipeline" refers to a key infrastructure project within the Sidara Collaborative's Zero Carbon Humber initiative, which aims to make the Humber region in the UK the first zero-carbon region. This pipeline network will be instrumental in transporting both carbon dioxide (CO2) and hydrogen, connecting energy-intensive industrial sites and enabling businesses to either capture their emissions or switch to hydrogen fuel.

Sidara require WG to be able to expand rapidly over the next 3 years as current and future projects demand it.

3rd April 2025, We continue to believe that the franchise has a substantial value, see below from Berenberg, WG shares could rise significantly after resolving the issues and making immediate changes to demonstrate that 2025/2026 will be outstanding.

What if the accounts are submitted before 30th April, the audit has been ongoing since November 2024, not an impossible task if enough resource is focused on it.

Berenberg will then set a new price target, which will be far greater then current price.

Analysts at Canaccord Genuity placed their target price and rating on oilfield services business Wood Group under review on Thursday, stating it was "lacking reasonable grounds" to take a stance on the stock.

Wood Group said earlier in the week that it does not expect to be able to publish results by 30 April and was now expecting to have its shares suspended from trading on the same date. It also stated that there was an expectation of material restatement of accounts for each of the past three years.

As a result, Berenberg no longer believe it has "a reasonable basis" for a price target on Wood.

"We continue to believe that the franchise has a substantial value, as indicated by the continuing discussions with Sidara, but we do not believe this is an adequate basis for a valuation," said the German bank.

Berenberg previously had a 'buy' rating and 250.0p target price on the stock

Same here, I have sold all other shares I own to have a large holding in WG, I think this is too good an opportunity to miss, added another 15820 today, roll on next week

Times cont

their high of more than 425p in March 2021 and it was demoted from the FTSE 250 mid-cap index in December. They closed at 103p on Thursday, down 9 per cent.

Miles Dixon, an analyst at Peel Hunt, the City investment bank which was appointed joint house broker this week, said: “There are not many more companies of which we can think that have a valuation disconnect as extreme as this.”

PureTech's market capitalisation of about £247 million compares with cash of about £282 million at the end of 2024.

The “valuation disconnect” was evidenced by PureTech revealing on Monday, amid the wider tariff-triggered market rout, that it was in talks with Nordic Capital, the US private equity firm, about a possible cash offer. The disclosure was prompted by a report on the deals website Betaville. Shares in PureTech rallied 7 per cent before Nordic Capital said that it had made a “private proposal” which had been rejected by PureTech's board.

Nordic walked away and is currently unlikely to return. The uncertainty caused by Trump's tariffs negotiations has sent a chill through the M&A market.

The abortive interest from Nordic is the second time that PureTech is publicly known to have attracted takeover interest: a bid failed to materialise three years ago when it exchanged non-binding proposals with Nektar Therapeutics, an American company.

PureTech's board led by Bharatt Chowrira, chief executive, must convince risk-averse investors of the potential of its portfolio, starting with its full-year results this month.

Advice Buy

Is it a good time to buy shares in PureTech Health?

Stock market fall and pause in Trump tariffs provide opportunity to assess potential bargains in biotechnology

Although the markets rout of the past week has been indiscriminate, for biotechnology, a riskier asset class at the best of times, it has felt brutal.

The London-listed biotech companies to have been sold off have included PureTech Health, which has lost almost 20 per cent of its value over the past five days and trades at new lows, despite attracting takeover interest.

The stock market fall and President Trump's 90-day tariffs pause have given investors an opportunity to take stock of potential bargains.

PureTech, based in Seaport, Boston, Massachusetts, listed on the London Stock Exchange in 2015 at 160p per share, when it raised £108 million and was valued at about £363.3 million. It joined a cluster of similar ventures seeking to reduce the risk of investing in biotech by creating a diversified portfolio of promising science and technology companies and assets.

The company, which went on to dual-list on New York's Nasdaq index in 2020, has built a pipeline of 29 therapies and drug candidates and has a clinical trial success rate of more than 80 per cent. Three of its assets have received marketing clearance in America, the world's biggest healthcare market.

Most notably, Karuna Therapeutics, a company founded by PureTech and floated on the Nasdaq exchange in 2019, successfully developed a treatment for schizophrenia by repurposing an Alzheimer's drug. Karuna was bought for $14 billion by Bristol Myers Squibb in March last year and the drug, KarXT, or Cobenfy, as it is branded, was approved by America's Food and Drug Administration in September.

The sale of Karuna crystallised $293 million for PureTech from its stake and remains eligible for up to another $400 million in future milestone and royalty payments. In turn, PureTech has returned $100 million to shareholders via a tender offer, which at the time represented about 14 per cent of its market capitalisation, and means it has returned a total of $150 million, including a $50 million share buyback.

Among its more recent, promising founded entities is Seaport Therapeutics, which is led by Daphne Zohar, PureTech's former chief executive and co-founder. Seaport, in which PureTech retains a 36.7 per cent stake, raised $100 million in a series A financing last April and is focused on the development of neuropsychiatric medicines. Seaport's founding investors — Arch Venture Partners, Sofinnova Investments and Third Rock Ventures — initially backed Karuna.

In December, one of PureTech's internal drug assets, deupirfenidone, had positive phase 2 trial results, showing slowed lung function decline in patients with idiopathic pulmonary fibrosis, a condition where the lungs become scarred and breathing becomes increasingly difficult.

Despite the therapeutic and commercial progress, PureTech's shares are down 75 per cent fro

S- John Wood Group's order book as of December 31, 2024, was approximately $6.2 billion, a significant increase from the $5.4 billion at the end of September 2024.

That is without new orders that have being signed and future orders to be signed within the next few months.

S- incorrect, lenders don’t own the company

Reckon Mambo_ jumbo, ShamI89 and Krok must share a desk in the office

S- Again incorrect information

ShamI89, give up your wasting your time with these stupid messages, suspension is not a problem for me if it happens, as Icecool has stated in his analysis, it’s a win

If Sidara walks, this still re-rates over 12–18 months. Debt refinanced, accounts filed, sentiment clears, easy recovery.

They will be no extension given, DD should be completed on or before 17th April